Figure 6. TNF scavenging in skeletal muscle arteries from animals and humans.
Myogenic and phenylephrine-stimulated vasoconstriction following treatment with etanercept (ETN, 300 μg ml−1 in vitro). (a,b) Dog gracilis skeletal muscle resistance arteries. (c,d) Pig gracilis skeletal muscle resistance arteries. (e,f) Human thoracic wall skeletal muscle resistance arteries. (g,h) Human lumbar skeletal muscle resistance arteries. Numbers in parentheses indicate arteries per group. All data are mean±s.e.m. *P<0.05 for unpaired Student's t-test comparison at each pressure.